These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 10311748)

  • 1. Cost benefit and cost effectiveness analysis: a bibliography for pharmacists.
    Lunik MC; Segal R
    Hosp Pharm; 1986 Nov; 21(11):1072-5. PubMed ID: 10311748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hospital diversification: bibliography on pharmaceutical services.
    Pearson RE; Barker KN; Harris JA
    Am J Hosp Pharm; 1987 Jun; 44(6):1325-33. PubMed ID: 3303923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hospital pharmacists versus hospital administrators: a struggle for clinical pharmacy services.
    De Rijdt T; Willems L; Simoens S
    Expert Rev Pharmacoecon Outcomes Res; 2009 Dec; 9(6):497-8. PubMed ID: 19941424
    [No Abstract]   [Full Text] [Related]  

  • 4. Proposed drug-drug cost effectiveness methodology.
    Gagnon JP; Osterhaus JT
    Drug Intell Clin Pharm; 1987 Feb; 21(2):211-6. PubMed ID: 3103997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacoeconomic series: Part I. Pharmacoeconomics and the evaluation of drugs and services.
    McGhan WF
    Hosp Formul; 1993 Apr; 28(4):365-6, 371-3, 377-8. PubMed ID: 10125323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Achieving provider support of pharmacy benefit design.
    Navarro RP
    Med Interface; 1995 Aug; 8(8):80-1, 84. PubMed ID: 10144776
    [No Abstract]   [Full Text] [Related]  

  • 7. Cost containment measures in hospital pharmacy: a bibliography.
    Treleaven S; Einarson TR
    Can J Hosp Pharm; 1990 Feb; 43(1):17-25. PubMed ID: 10106452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A proposed model for conducting institutional-specific cost-effectiveness analysis: a case study of lipid-lowering agents.
    Hakim Z; Pierson JF; Pathak DS
    Pharm Pract Manag Q; 1996 Apr; 16(1):79-97. PubMed ID: 10157744
    [No Abstract]   [Full Text] [Related]  

  • 9. Cost effectiveness: pharmacy systems.
    Bishop SA
    Ohio State Med J; 1979 May; 75(5):287-9. PubMed ID: 111189
    [No Abstract]   [Full Text] [Related]  

  • 10. Cost-benefit and cost-effectiveness: methodologies for evaluating innovative pharmaceutical services.
    McGhan WF; Rowland CR; Bootman JL
    Am J Hosp Pharm; 1978 Feb; 35(2):133-40. PubMed ID: 415603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacoeconomics: therapeutic and economic considerations in treating the critically ill patient.
    Crane VS
    DICP; 1990 Nov; 24(11 Suppl):S24-7. PubMed ID: 2125394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The 1982 Hoechst Lecture: "Cost effectiveness--the emerging 'bottom line' for pharmacy?!".
    Marshman JA
    Can J Hosp Pharm; 1982; 35(2):39-41. PubMed ID: 10309676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-benefit of a clinical services integrated with a decentralized unit dose system.
    Warrian K; Irvine-Meek J
    Can J Hosp Pharm; 1988 Jun; 41(3):109-12. PubMed ID: 10312603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An assessment of the impact and value of clinical pharmacy services.
    Cohen MR; Turco SJ; Weltmann AJ
    Hosp Pharm; 1977 Jan; 12(1):9-10, 12-4, 19-20. PubMed ID: 10305424
    [No Abstract]   [Full Text] [Related]  

  • 15. Prospective-pricing strategies for hospital and departmental effectiveness: the administrator's response.
    Van Etten P
    Am J Hosp Pharm; 1985 Oct; 42(10):2153-8. PubMed ID: 3933334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determining the differences among cost savings, cost avoidance, and cost reduction.
    Howard KB; Pathak DS
    Pharm Pract Manag Q; 1999 Oct; 19(3):1-7. PubMed ID: 10747680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost justifying a pharmacy residency program.
    Schneider PJ; Boman DM; Bourret JA; Ngu BQ; Ouellette SM; Smeek DM
    Am J Hosp Pharm; 1982 Sep; 39(9):1517-20. PubMed ID: 6814246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacoeconomic factors in the treatment of acute hypertension.
    Shulkin DJ
    Hosp Formul; 1994 Aug; 29 Suppl 2():S15-20. PubMed ID: 10135742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacoeconomic principles and methods: an introduction for hospital pharmacists.
    Sanchez LA
    Hosp Pharm; 1994 Aug; 29(8):774, 777-9. PubMed ID: 10135744
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical pharmacists can ensure quality at acceptable costs.
    Skaar DJ; Oki JC; Elenbaas RM
    Healthc Financ Manage; 1991 Dec; 45(12):90, 92. PubMed ID: 10145551
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.